Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added revision 3.5.0 to the history and removed revision 3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T09:08:25.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Added revision v3.4.3 to the record history and removed the previous v3.4.2 entry.
    Difference
    0.1%
    Check dated 2026-03-06T19:16:53.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page shows a minor site version update: Revision v3.4.2 added and Revision v3.4.1 removed. This change does not affect the study data or history content displayed on the page.
    Difference
    0.1%
    Check dated 2026-02-13T12:55:31.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision history shows the addition of v3.4.1 and the deletion of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T23:37:55.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.3.4) added and the previous revision (v3.3.3) removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T04:49:02.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 in the page footer; these are administrative history/version updates and do not affect study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-24T14:41:08.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.